IDiyas

For the Inventor, By the Inventor

Westfield, NJ, United States of America

Kenneth E Wilson

USPTO Granted Patents = 16 

Average Co-Inventor Count = 3.6

ph-index = 6

Forward Citations = 80(Granted Patents)


Location History:

  • Woodbridge, NJ (US) (1979)
  • Westfield, NJ (US) (1981 - 1992)

Company Filing History:

goldMedal16 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1979-1992

Loading Chart...
16 patents (USPTO):Explore Patents
1. 5164375 - Antifungal agent (1992-11-17),
2. 5091413 - Antibiotic agent (1992-02-25),
3. 5021453 - 3-keto HMG-CoA reductase inhibitors (1991-06-04),
4. 4968693 - 3-keto HMG-COA reductase inhibitors (1990-11-06),
5. 4816448 - Thermal isomer of difficidin and thermal isomer of oxydifficidin (1989-03-28),
6. 4806565 - Antifugal tri-yne carbonates (1989-02-21),
7. 4681846 - Process for the preparation of difficidin and derivative antibacterials (1987-07-21),
8. 4656036 - Antibiotics Tejeramycin and production thereof (1987-04-07),
9. 4609742 - Difficol, intermediate in antibiotic preparation (1986-09-02),
10. 4545991 - Difficidin and derivative antibacterials (1985-10-08),
11. 4476139 - Discovery of antibiotic L-681,217 in fermentation broth (1984-10-09),
12. 4374772 - Process for the preparation of N-formimidoyl thienamycin and reagents (1983-02-22),
13. 4335212 - Fermentation process for (1982-06-15),
14. 4247640 - Fermentation process for (1981-01-27),
15. 4161583 - Method for the separation and purification of antibiotic macrolides (1979-07-17),

Title: Kenneth E. Wilson: Innovator in Antifungal and Antibiotic Agents

Introduction

Kenneth E. Wilson is a prominent inventor based in Westfield, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antifungal and antibiotic agents. With a total of 16 patents to his name, Wilson's work has had a substantial impact on medical science.

Latest Patents

Among his latest patents, Wilson has developed an antifungal agent characterized by a phospholipid formula that exhibits antifungal properties. Additionally, he has created an antibiotic agent derived from the cultivation of Dictyochaeta simplex, which demonstrates broad antifungal activity and antipneumocystis activity. These innovations highlight his commitment to advancing healthcare solutions.

Career Highlights

Kenneth E. Wilson is currently associated with Merck & Company, Inc., a leading global healthcare company. His role at Merck has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to pharmaceutical research and development.

Collaborations

Some of Wilson's notable coworkers include Otto D. Hensens and Sheldon B. Zimmerman. Their collaborative efforts have played a crucial role in the success of various projects and innovations within the company.

Conclusion

Kenneth E. Wilson's work in developing antifungal and antibiotic agents showcases his dedication to improving health outcomes. His numerous patents and collaborations reflect his significant influence in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…